Innovent receives NMPA approval for Taletrectinib Adipate capsule from NMPA
DOVBLERON marks the 13th addition to Innovent’s commercial portfolio
DOVBLERON marks the 13th addition to Innovent’s commercial portfolio
Innovent has granted Roche exclusive global rights to develop, manufacture and commercialize IBI3009
Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture and commercialize HS-10535
A 40 minute daily Yoga routine, incorporating select asanas and pranayama, along with standard lifestyle interventions, can reduce the risk of developing diabetes by approximately 40%
CSPC will receive an upfront payment of $100 million from AstraZeneca
MNI is dedicated to developing and offering phytochemical (plant-based) products and healthcare solutions, aimed at treating metabolic syndrome
India has taken the lead in recognising NAFLD as a major non-communicable disease
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
Subscribe To Our Newsletter & Stay Updated